NDC 0006-5425

BRIDION

Sugammadex

BRIDION is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Sugammadex Sodium.

• Product ID: 0006-5425_16317d73-43c1-4adc-8828-8d48f2998861
• NDC: 0006-5425
• Product Type: Human Prescription Drug
• Proprietary Name: BRIDION
• Generic Name: Sugammadex
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2015-12-15
• Marketing Category: NDA / NDA
• Application Number: NDA022225
• Labeler Name: Merck Sharp & Dohme Corp.
• Substance Name: SUGAMMADEX SODIUM
• Active Ingredient Strength: 100 mg/mL
• Pharm Classes: gamma-Cyclodextrins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0006-5425-15

10 VIAL, SINGLE-DOSE in 1 CARTON (0006-5425-15) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-5425-05)

• Marketing Start Date: 2017-06-05
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0006-5425-05 [00006542505]

BRIDION INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA022225
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2015-12-15

NDC 0006-5425-15 [00006542515]

BRIDION INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA022225
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-06-05

Drug Details

Active Ingredients

Ingredient	Strength
SUGAMMADEX SODIUM	100 mg/mL

OpenFDA Data

• SPL SET ID: 5171d883-fe8f-482c-97ab-40b00975b64a
• Manufacturer:
  • Merck Sharp & Dohme Corp.
• UNII:
  • ERJ6X2MXV7
• RxNorm Concept Unique ID - RxCUI:
  • 1727000
  • 1727001
  • 1726997
  • 1726992

Pharmacological Class

• gamma-Cyclodextrins [CS]
• gamma-Cyclodextrins [CS]

NDC Crossover Matching brand name "BRIDION" or generic name "Sugammadex"

NDC	Brand Name	Generic Name
0006-5423	BRIDION	sugammadex
0006-5425	BRIDION	sugammadex
71872-7187	BRIDION	sugammadex